Barclays Maintains Underweight on FMC, Lowers Price Target to $4
Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Underweight and lowers the price target from $9 to $4.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Underweight and lowers the price target from $9 to $4.
BMO Capital analyst Joel Jackson maintains FMC (NYSE:FMC) with a Market Perform and lowers the price target from $11 to $7.5.
Analysts downgraded Varonis, Eastman Chemical, Workday and FMC; price targets fell for Eastman, Varonis and FMC.